Related Experiment Video
Updated: Oct 24, 2025

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer
Hongxu Li1,2,3,4, Jie Gao1,2,3,4, Shuijun Zhang1,2,3,4
1Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
The cell adhesion molecule CADM1, which participates in cell adhesion and signal transduction, has a regulatory effect on the development of tumors. CADM1 is often involved in malignant tumors of multiple organ systems, such as the respiratory and digestive systems. Upregulated CADM1 promotes tumor cell apoptosis and inhibits malignant proliferation. Along with cell cycle-related proteins, it participates in regulating signaling pathways, such as EMT, STAT3, and AKT, and plays an important role in inhibiting invasion and migration. Considering clinical characteristics, low CADM1 expression is associated with aggressive tumors and poor prognosis. In addition, some long non-coding RNAs (lncRNAs) or miRNAs directly or indirectly act on CADM1 to regulate tumor growth and motility. Interestingly, CADM1 function differs in adult T-cell leukemia/lymphoma (ATLL), and NF-κB is thought to be involved in this process. Taken together, CADM1 could be a potential biomarker for early diagnosis and a target for cancer treatment in future clinical practices.
Insights
The cell adhesion molecule CADM1 impacts tumor development by promoting apoptosis and inhibiting proliferation. Low expression correlates with aggressive cancers, suggesting CADM1 as a potential diagnostic biomarker and therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cell adhesion molecule CADM1 regulates cell adhesion and signal transduction.
- CADM1 involvement in malignant tumors across various organ systems, including respiratory and digestive tracts.
- Dysregulation of CADM1 impacts tumor progression and patient outcomes.
Purpose of the Study:
- To investigate the role of CADM1 in tumor development and progression.
- To explore the association between CADM1 expression levels and clinical characteristics.
- To identify CADM1 as a potential biomarker for early cancer diagnosis and a therapeutic target.
Main Methods:
- Analysis of CADM1 expression in tumor tissues.
- Correlation studies between CADM1 levels and clinicopathological features.
- Investigation of signaling pathways regulated by CADM1, including EMT, STAT3, and AKT.
- Exploration of regulatory mechanisms involving lncRNAs and miRNAs on CADM1.
Main Results:
- Upregulated CADM1 expression promotes tumor cell apoptosis and inhibits malignant proliferation.
- CADM1 regulates key signaling pathways (EMT, STAT3, AKT), inhibiting invasion and migration.
- Low CADM1 expression is linked to aggressive tumor phenotypes and poor prognosis.
- Specific roles of CADM1 in adult T-cell leukemia/lymphoma (ATLL) involving NF-κB.
Conclusions:
- CADM1 plays a significant role in tumor suppression, affecting proliferation, apoptosis, invasion, and migration.
- CADM1 expression levels serve as a prognostic indicator for various cancers.
- CADM1 represents a promising biomarker for early cancer detection and a potential target for novel therapeutic strategies.
Related Concept Videos
Structure of Cadherins
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Cancer Cell Migration through Invadopodia

